Top Markets
#1 PulseChain PulseChain +45.01%
#2 SkyAI SkyAI +14.51%
#3 Pump.fun Pump.fun +10.70%
#4 Unit Pump Unit Pump +10.70%
#5 Meteora Meteora +9.22%
#6 Glidr Glidr +8.75%
#7 OPENLOOT OPENLOOT +8.70%
#8 eCash eCash +8.55%
#9 Fake World Assets Fake World Assets +8.16%
#10 Verus Coin Verus Coin +7.75%
Coin of the day
PulseChain PulseChain
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Oxygenta Pharmaceutical Ltd. Oxygenta Pharmaceutical Ltd.

Oxygenta Pharmaceutical Ltd.

OXYGENTAPH
Rangering i aksjer #28277
Oxygenta Pharmaceutical Ltd. focuses on the formulation and production of... Oxygenta Pharmaceutical Ltd. focuses on the formulation and production of active pharmaceutical ingredients. Their offerings specifically encompass medications used to treat ulcers and fight bacterial infections. The company commenced operations on November 27, 1990, and maintains its primary base in Hyderabad, India.
Aksjekurs
$0.74183167
Sist synkronisert: 2026-08-19
Markedsverdi
$27.44M
Endring (1 dag)
-0.01%
Endring (1 år)
-20.70%
Land
IN
Handel Oxygenta Pharmaceutical Ltd. (OXYGENTAPH)

Kategori

Healthcare
P/B-forhold for Oxygenta Pharmaceutical Ltd. (OXYGENTAPH)
P/B-forhold per 2026 TTM: 0
Ifølge Oxygenta Pharmaceutical Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Oxygenta Pharmaceutical Ltd. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.817 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 2.4038 -
HK
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0911 -
US